Assignee
SEATTLE GENETICS INC
US·87 granted patents·72 pending applications·6,062 citations·filing 1999–2020
Top patents by PatentIndex Score
159 records- 0199US10808039B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2019·Granted Oct 20, 2020·18 cites·10 claims
- 0299US8039273B2β-glucuronide-linker drug conjugatesSEATTLE GENETICS INC·Filed 2006·Granted Oct 18, 2011·94 cites·27 claims
- 0399US7994135B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Aug 9, 2011·164 cites·51 claims
- 0499US7989434B2Heterocyclic self-immolative linkers and conjugatesSEATTLE GENETICS INC·Filed 2010·Granted Aug 2, 2011·127 cites·19 claims
- 0599US7964566B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·209 cites·60 claims
- 0699US7964567B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·134 cites·42 claims
- 0799US7851437B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Dec 14, 2010·163 cites·42 claims
- 0899US7829531B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Nov 9, 2010·199 cites·81 claims
- 0999US7754681B2Heterocyclic self-immolative linkers and conjugatesSEATTLE GENETICS INC·Filed 2007·Granted Jul 13, 2010·229 cites·19 claims
- 1099US7745394B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 29, 2010·193 cites·44 claims
- 1199US7659241B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2003·Granted Feb 9, 2010·442 cites·78 claims
- 1299US7553816B2p-amidobenzylethers in drug delivery agentsSEATTLE GENETICS INC·Filed 2002·Granted Jun 30, 2009·178 cites·51 claims
- 1399US7498298B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2004·Granted Mar 3, 2009·1.1k cites·22 claims
- 1499US7375078B2Heterocyclic self-immolative linkers and conjugatesSEATTLE GENETICS INC·Filed 2005·Granted May 20, 2008·326 cites·3 claims
- 1599US7091186B2p-Amidobenzylethers in drug delivery agentsSEATTLE GENETICS INC·Filed 2001·Granted Aug 15, 2006·211 cites·38 claims
- 1699US6884869B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2001·Granted Apr 26, 2005·562 cites·2 claims
- 1798US9713647B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Jul 25, 2017·26 cites·10 claims
- 1898US7968687B2CD19 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2008·Granted Jun 28, 2011·139 cites·14 claims
- 1998US7750116B1Antibody drug conjugate metabolitesSEATTLE GENETICS INC·Filed 2007·Granted Jul 6, 2010·199 cites·1 claims
- 2098US7098308B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2004·Granted Aug 29, 2006·101 cites·6 claims
- 2197US9701752B2Humanized anti-CD70 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2016·Granted Jul 11, 2017·30 cites·25 claims
- 2297US8343928B2Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminusSEATTLE GENETICS INC·Filed 2006·Granted Jan 1, 2013·55 cites·26 claims
- 2397US7837980B2Partially loaded antibodies and methods of their conjugationSEATTLE GENETICS INC·Filed 2005·Granted Nov 23, 2010·98 cites·26 claims
- 2497US7491390B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersSEATTLE GENETICS INC·Filed 2005·Granted Feb 17, 2009·60 cites·28 claims
- 2597US7423116B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2006·Granted Sep 9, 2008·51 cites·24 claims
- 2697US7090843B1Recombinant anti-CD30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2000·Granted Aug 15, 2006·155 cites·18 claims
- 2796US10722549B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2019·Granted Jul 28, 2020·7 cites·23 claims
- 2896US9592240B2Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Mar 14, 2017·23 cites·11 claims
- 2996US9526798B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2012·Granted Dec 27, 2016·21 cites·4 claims
- 3096US7666422B2Methods for the treatment of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2009·Granted Feb 23, 2010·30 cites·17 claims
- 3196US7256257B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2002·Granted Aug 14, 2007·69 cites·52 claims
- 3295US10414826B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2017·Granted Sep 17, 2019·8 cites·20 claims
- 3395US9919061B2CD19 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2015·Granted Mar 20, 2018·9 cites·16 claims
- 3495US9707301B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Jul 18, 2017·21 cites·10 claims
- 3595US9504756B2Self-stabilizing linker conjugatesSEATTLE GENETICS INC·Filed 2013·Granted Nov 29, 2016·26 cites·15 claims
- 3695US9428585B2Humanized anti-CD70 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2013·Granted Aug 30, 2016·26 cites·31 claims
- 3795US7641903B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersSEATTLE GENETICS INC·Filed 2007·Granted Jan 5, 2010·45 cites·22 claims
- 3895US6843989B1Methods for the treatment and prevention of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2000·Granted Jan 18, 2005·57 cites·78 claims
- 3995US6838261B1Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteinsSEATTLE GENETICS INC·Filed 2000·Granted Jan 4, 2005·61 cites·35 claims
- 4094US10098963B2Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2017·Granted Oct 16, 2018·10 cites·8 claims
- 4194US9713648B2Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2015·Granted Jul 25, 2017·11 cites·4 claims
- 4294US9387259B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2012·Granted Jul 12, 2016·24 cites·22 claims
- 4394US7824683B2Methods for augmenting an immune response using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2009·Granted Nov 2, 2010·18 cites·14 claims
- 4494US7695716B2Methods of treating neoplastic, autoimmune and inflammatory diseasesSEATTLE GENETICS INC·Filed 2008·Granted Apr 13, 2010·75 cites·38 claims
- 4593US9816069B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2015·Granted Nov 14, 2017·6 cites·20 claims
- 4693US9463252B2Auristatin drug linker conjugatesSEATTLE GENETICS INC·Filed 2013·Granted Oct 11, 2016·13 cites·43 claims
- 4793US8993326B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2013·Granted Mar 31, 2015·9 cites·20 claims
- 4893US6946129B1Recombinant anti-CD40 antibody and uses thereofSEATTLE GENETICS INC·Filed 1999·Granted Sep 20, 2005·70 cites·21 claims
- 4992US10478469B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2019·Granted Nov 19, 2019·6 cites·30 claims
- 5092US8992932B2Binder-drug conjugates (ADCs) and use thereofSEATTLE GENETICS INC·Filed 2012·Granted Mar 31, 2015·26 cites·12 claims
Showing the top 50 of 159 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SEATTLE GENETICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →